Janux Therapeutics (JANX) Shares Issued (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Shares Issued of $10.4 million for Q1 2026, up 3.91% year-over-year from $10.0 million in Q1 2025, and up 8.78% quarter-over-quarter from $9.5 million in Q4 2025.
Janux Therapeutics (JANX) Shares Issued (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Shares Issued for 7 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 3.91% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (up 3.91% YoY), while the FY2025 annual figure was $9.5 million, up 7.6% from the prior year.
- Shares Issued rose to $10.4 million in Q1 2026 per JANX's latest filing, from $9.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $10.4 million in Q1 2026 and bottomed at $5.0 million in Q1 2022.
- Historically, Shares Issued has averaged $8.4 million across 5 years, with a median of $8.9 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Issued surged 78.41% — and 2024, when it slumped 36.96%.
- Janux Therapeutics' Shares Issued stood at $7.3 million in 2022, then grew by 8.76% to $8.0 million in 2023, then grew by 11.06% to $8.9 million in 2024, then gained by 7.6% to $9.5 million in 2025, then advanced by 8.78% to $10.4 million in 2026.
- Business Quant data shows JANX's Shares Issued at $10.4 million in Q1 2026, $9.5 million in Q4 2025, and $10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.02 Mn |
| Jun 30, 2026 | 10.02 Mn |
| Mar 31, 2026 | 10.39 Mn |
| Mar 31, 2026 | 10.39 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Sep 30, 2025 | 9.95 Mn |
| Sep 30, 2025 | 9.95 Mn |
| Jun 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 10.21 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 8.87 Mn |
| Dec 31, 2024 | 8.87 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 9.66 Mn |
| Jun 30, 2024 | 9.66 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Mar 31, 2024 | 5.60 Mn |